Dermot Murnaghan ‘fell through the gaps' with stage four cancer diagnosis
Speaking at an event for Prostate Cancer UK, the broadcaster shared his diagnosis journey and urged men to get tested.
He said: 'For years I thought 'that will do me' I'm getting tested basically once a year or every couple of years.
'It never occurred to me that they weren't testing for PSA (prostate-specific antigen) and I never went to my GP because I was getting other tests privately through the production company.
'So that's how I fell through the gaps and that's how I had a massive wake-up call and want to share the message.'
Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, such as the back passage or bladder, and other parts of the body outside the pelvis, such as the bones, lungs or liver, according to the Cancer Research UK website.
About one in eight men will get prostate cancer in their lifetime, according to the charity Prostate Cancer UK, however, there currently are no screening programmes for men to get tested.
One option is a PSA blood test which checks the level of prostate-specific antigens in the blood. A high reading may be a sign of a prostate condition.
NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one.
Murnaghan added: 'You can get to the stage I have with no symptoms.
'Get the test, insist on the test. You can insist on the test if you are in a high-risk group and under 50. If you are not, I'd still get the test at 50.
'Go to your GP and they say you don't need it but say 'but I want it'. It is your right to have it. Just keep doing that every year or couple of years. Once you've got that marker where your PSA is, keep monitoring it.
'The earlier you find prostate cancer the easier it is to treat, so check your risk in just 30 seconds with Prostate Cancer UK's online risk checker to see if you are at risk and what you can choose to do about it.'
The presenter also shared an update on his treatment, adding that 'there is a lot of hope' with new trials and options available.
He said: 'In terms of the treatments for the stage I'm at, they are a myriad. What's astonishing is just how fast things are developing, even at last stage advanced prostate cancer, the treatment I'm on, the programme that I've been getting only really was approved within the last couple of years.
'There is a lot of hope out there, there's a lot going on, there's a lot of advice and a lot of things happening there. So as a sufferer and a non-medical person my advice is, ask questions. There are always different ways of doing things, slightly, but just keep asking those questions about where you are, what there is available or even if perhaps you could access one of those clinical trials yourself.'
The broadcaster will join Sir Chris Hoy's fundraising charity bike ride, Tour de 4, to raise awareness and funds for chancer charities across the UK.
The Olympian announced he had a terminal diagnosis for prostate cancer in October 2024.
Murnaghan added: 'I'm really proud to be supporting Prostate Cancer UK and taking part in Sir Chris Hoy's fundraising event, the Tour de 4. This groundbreaking cycling challenge is raising vital funds for cancer charities and changing the conversation.
'I'll be riding in Glasgow this September alongside some incredible participants, all to raise awareness and help save men's lives. Prostate Cancer UK means a lot to me and I'd love for you to get involved and show your support. Together we can make a real difference.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Guardian
an hour ago
- South Wales Guardian
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Times
an hour ago
- Times
I was a Gen Z screen addict. Then I took drastic action
A lot can happen in seven hours. You could fly from London to Dubai, get through a full school day or enjoy a luxurious night's sleep. Me? I used to spend seven hours a day staring at my phone screen. Now I average less than one. I'm 22 and I've spent an alarming percentage of my life glued to my phone. It was everything — my entertainment, my social lifeline, my procrastination tool, my 3am therapist. I'm far from alone. Data shows that Generation Z's daily screen time is on average more than nine hours a day, which is more than any other generation. That's about 136 days a year spent staring at a screen. Meanwhile, the NHS reports a steep rise in mental health disorders among young people, which tracks closely with the explosion in digital device use.
Leader Live
2 hours ago
- Leader Live
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
